neoplasm
• 71% of F1 progeny develop lymphomas before 30 weeks of age
• when F1 mice are backcrossed to C57BL/6, 46% of offspring develop lymphomas between 11 and 35 weeks of age
• tumors from affected mice involve spleen, lymph nodes, thymus, bone marrow, liver and often kidneys or lungs; tumors are lymphblastic with proliferation of monotonous medium-sized cells with nucleoli
|
• all tumors analyzed express alpha, beta TCR and lack expression of B cell markers B220 and sIg
• in transplant experiments, syngeneic reciepients of tumor cells develop T cell lymphomas within 14 days
|
cellular
• tumors show a high rate of cell death
|
• tumors show high mitotic indices with S-phase fractions between 25 and 35%
|
endocrine/exocrine glands
• all tumors analyzed express alpha, beta TCR and lack expression of B cell markers B220 and sIg
• in transplant experiments, syngeneic reciepients of tumor cells develop T cell lymphomas within 14 days
|
immune system
• all tumors analyzed express alpha, beta TCR and lack expression of B cell markers B220 and sIg
• in transplant experiments, syngeneic reciepients of tumor cells develop T cell lymphomas within 14 days
|
hematopoietic system
• all tumors analyzed express alpha, beta TCR and lack expression of B cell markers B220 and sIg
• in transplant experiments, syngeneic reciepients of tumor cells develop T cell lymphomas within 14 days
|